NASDAQ: QSIQuantum Si Inc Stock
$1.63+0.06 (+3.82%)
Updated May 26, 2023
QSI Price
$1.63
Fair Value Price
$2.18
Market Cap
$230.64M
52 Week Low
$1.36
52 Week High
$4.65
P/E
-1.87x
P/B
0.68x
P/S
972.02x
PEG
N/A
Dividend Yield
N/A
Revenue
$254.00k
Earnings
-$120.88M
Gross Margin
48.8%
Operating Margin
-47,589.76%
Profit Margin
-47,589.8%
Debt to Equity
0.08
Operating Cash Flow
-$96M
Beta
1.72
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
QSI Overview
Quantum-Si incorporated, a life sciences company, offers a single molecule detection platform that enables nextgen protein sequencing and is used in DNA applications. Quantum-Si was incorporated in 2013 is based in Guilford, CT.
Zen Score
–
Industry Average (26)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how QSI scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
QSI ($1.63) is undervalued by 25.07% relative to our estimate of its Fair Value price of $2.18 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
QSI ($1.63) is significantly undervalued by 25.07% relative to our estimate of its Fair Value price of $2.18 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety
Significantly Below Fair Value Valuation
QSI is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more QSI due diligence checks available for Premium users.
Be the first to know about important QSI news, forecast changes, insider trades & much more!
QSI News
Valuation
QSI fair value
Fair Value of QSI stock based on Discounted Cash Flow (DCF)
Price
$1.63
Fair Value
$2.18
Undervalued by
25.07%
QSI ($1.63) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
QSI ($1.63) is significantly undervalued... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
QSI is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
QSI price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-1.87x
Industry
11.86x
Market
54.23x
QSI price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
0.68x
Industry
5.18x
QSI is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
QSI's financial health
Profit margin
Revenue
$254.0k
Net Income
-$23.6M
Profit Margin
-9,295.7%
QSI's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
QSI's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$365.0M
Liabilities
$26.0M
Debt to equity
0.08
QSI's short-term assets ($330.02M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
QSI's short-term assets ($330.02M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
QSI's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$28.7M
Investing
$26.0M
Financing
$0.0
QSI's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
QSI vs Biotech Stocks
Quantum Si Stock FAQ
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.